Biodexa Pharmaceuticals Plc - ADR

Biodexa Pharmaceuticals Plc - ADR

BDRX - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$64.01M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Biodexa Pharmaceuticals Plc - ADRBiodexa Pharmaceuticals Plc - ADR-64--112%--
$0.41

Current Fair Value

88% downside

Overvalued by 88% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$64.01 Million
Enterprise Value$60.80 Million
Earnings per Share$-0.32
Beta1.28
Outstanding Shares18,661,534

Return

Return on Equity-111.65%ROE
Return on Assets-84.37%
Return on Invested Capital-186.81%

Valuation & Multiples

P/E Ratio-64.01P/E Ratio
PEG126.43PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT0.16
Enterprise Value to Net Income-6
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 11, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
April 23, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Biodexa Pharmaceuticals Plc

20 employees

Biodexa Pharmaceuticals Plc Insider Information FAQ

In the latest 13F quarter on Stockcircle, 1 top investor reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.